Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines
by David M. Lewinsohn, Michael K. Leonard, Philip A. LoBue et al.
Clin Infect Dis. (2016) – First published online: December 8, 2016
Individuals infected with Mycobacterium tuberculosis (Mtb) may develop symptoms and signs of disease (TB disease) or may have no clinical evidence of disease (latent tuberculosis infection [LTBI]). TB disease is a leading cause of infectious disease morbidity and mortality worldwide, with many diagnostic uncertainties. A task force supported by the supported by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America appraised the evidence and derived the following recommendations using the Grading, Recommendations, Assessment, Development, and Evaluation (GRADE) approach.